Last reviewed · How we verify
rutoside
rutoside is a drug. It is currently in unknown development for Ascorbic acid deficiency.
At a glance
| Generic name | rutoside |
|---|---|
| Target | Bifunctional epoxide hydrolase 2, Lysine-specific histone demethylase 1A, Neuromedin-U receptor 2 |
| Therapeutic area | Neuroscience |
| Phase | unknown |
Approved indications
- Ascorbic acid deficiency
Common side effects
Key clinical trials
- The Effect of Oral Water and Ice Popsicle on Management of Thirst in the Immediate Postoperative Period. (NA)
- Clinical Study of Non-inferiority Between Aesculus Hippocastanum 50mg, Polygonum Acre 10mg, Smilax Pepyracea 40mg, Rutin 20mg Versus Diosmin 450mg and Hesperidin 50mg Tablets in Chronic Venous Insuffi (Phase 4)
- Rutin Therapy Reduces Ulcerative Colitis Disease Activity By Inhibiting The NOD-Like Receptor Protein 3 (NLRP3) Inflammasome: A Molecular Assessment in a Case-Control Study (NA)
- Resolution Enhancement by a Supplemental Obstruction Lessening Venoactive Drug for Eight Weeks in Deep Vein Thrombosis: A Pilot Study to Evaluate if Hydroxyethylrutoside Reduces the Risk of Post-Throm (Phase 3)
- The Effect of Preoperative Education on Kinesiophobia in Patients Undergoing Total Knee Replacement Surgery: A Randomized Controlled Study (NA)
- Evaluation of The Effect of Rutin and Vitamin C on the Oxidative Stress in Hemodialysis Patients (Phase 3)
- The Effect of Web-Based Training on the Anxiety and Early Recovery Outcomes of Thyroidectomy Patients: Randomized Controlled Study (NA)
- The Effect of Education Given Before Port Catheter Infusion on Infusion Related Symptoms (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- rutoside CI brief — competitive landscape report
- rutoside updates RSS · CI watch RSS
- portfolio CI
Frequently asked questions about rutoside
What is rutoside?
rutoside is a pharmaceutical drug, indicated for Ascorbic acid deficiency.
What is rutoside used for?
rutoside is indicated for Ascorbic acid deficiency.
What development phase is rutoside in?
rutoside is in unknown.
What does rutoside target?
rutoside targets Bifunctional epoxide hydrolase 2, Lysine-specific histone demethylase 1A, Neuromedin-U receptor 2.
Related
- Target: All drugs targeting Bifunctional epoxide hydrolase 2, Lysine-specific histone demethylase 1A, Neuromedin-U receptor 2
- Manufacturer: — full pipeline
- Therapeutic area: All drugs in Neuroscience
- Indication: Drugs for Ascorbic acid deficiency
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing